Área de PDI em DST/AIDS 2012
Afonso JM, Morgado MG, Bello G, Evidence of multiple introductions of HIV-1 subtype C in Angola, 2012, Infection Genetics and Evolution, Oct;12(7):1458-65. http://www.sciencedirect.com/science/article/pii/S1567134812001852
Afonso JM, Bello G, Guimarães ML, Sojka M, Morgado MG. HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola. PLoS One. 2012;7(8):e42996. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042996
Aires, RS; Matos, MA; Lopes, CL; Teles, SA; Kozlowski, AG; Silva, AM; Filho, JA; Lago, BV; Mello, FC & Martins, RM. 2012. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil. J Clin Virol., 54 (4): 327-31. http://www.sciencedirect.com/science/article/pii/S1386653212001552
Alcalde R, Guimarães ML, Duarte AJ, Casseb J.Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil. Virology Journal. 2012 Aug 9;9:156. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511064/
Almeida SE, de Medeiros RM, Junqueira DM, Gräf T, Passaes CP, Bello G, Morgado MG, L Guimarães M, Temporal dynamics of HIV-1 circulating subtypes in distinct exposure categories in Southern Brazil, Virology Journal, 2012 Dec 12;9:306. http://www.virologyj.com/content/9/1/306
Aulicino PC; Gómez-Carrillo M; Bello G; Rocco C; Mangano A; Carr J; Sen L; Foley B; Characterization of full-length HIV-1 CRF17_BF genomes and comparison to the prototype CRF12_BF strains, 2012, Infection, Genetics and Evolution, Volume 12 Issue 2, pages 443-447. http://www.sciencedirect.com/science/article/pii/S1567134812000044
Bello G, Afonso JM, Morgado MG, Phylodynamics of HIV-1 subtype F1 in Angola, Brazil and Romania, 2012, Infection, Genetics and Evolution;12(5):1079-86. http://www.sciencedirect.com/science/article/pii/S1567134812000949
Bello G, Zanotto PM, Iamarino A, Gräf T, Pinto AR, Couto-Fernandez JC, Morgado MG., Phylogeographic analysis of HIV-1 subtype C dissemination in Southern Brazil, 2012, PLoS One, 7(4):e35649. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035649
Cecchetto F, Monteiro S, Vargas E. Sociabilidade juvenil, cor, gênero e sexualidade no baile charme carioca. Cadernos de Pesquisa. 2012. vol.42 no.146. http://www.scielo.br/pdf/cp/v42n146/en_08.pdf
De Cicco RR, Portes Vargas E. As doenças sexualmente transmissíveis em livros didáticos de biologia: aportes para o ensino de ciência. Revista Electrónica de Investigación em Educación em Ciencias. 2012. ISSN 1850-6666. http://www.scielo.org.ar/pdf/reiec/v7n1/v7n1a02.pdf
Delatorre EO, Bello G. Phylodynamics of HIV-1 subtype C epidemic in East Africa. PLoS One. 2012;7(7):e41904. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0041904
Delatorre EO, Bello G, Eyer-Silva WA, Chequer-Fernandez SL, Morgado MG, Couto-Fernandez JC. Evidence of multiple introductions and autochthonous transmission of the HIV type 1 CRF02_AG clade in Brazil. AIDS Research and Human Retroviruses. 2012 Oct;28(10):1369-72. http://online.liebertpub.com/doi/pdf/10.1089/aid.2011.0381
do Amaral Mello FC; Carlos Augusto Fernandes CA; Gomes AS, Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes, 2012, Memórias do Instituto Oswaldo Cruz, vol.107 no.3. http://memorias.ioc.fiocruz.br/issues/past-issues/item/1259-antiviral-therapy-against-chronic-hepatitis-b-in-brazil-high-rates-of-lamivudine-resistance-mutations-and-correlation-with-hbv-genotypes
Faro LV, de Almeida JM, Cirne-Santos CC, Giongo VA, Castello-Branco LR, Oliveira Ide B, Barbosa JE, Cunha AC, Ferreira VF, de Souza MC, Paixão IC, de Souza MC.Oxoquinoline acyclonucleoside phosphonate analogues as a new class of specific inhibitors of human immunodeficiency virus type 1. Bioorganic & Medicinal Chemistry Letters. 2012 Aug 1;22(15):5055-8. http://www.sciencedirect.com/science/article/pii/S0960894X12007676
Gudo ES Jr, Bhatt NB, Augusto O, Semá C, Savino W, Ferreira OC Jr, Jani IV, Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients, International Journal of STD & AIDS, 2012 Oct;23(10):717-23. http://www.ncbi.nlm.nih.gov/pubmed/23104746
Guimarães ML, Velarde-Dunois KG, Segurondo D, Morgado MG, The HIV-1 epidemic in Bolivia is dominated by subtype B and CRF12_BF "family" strains, 2012, Virology Journal, 16;9:19. http://www.virologyj.com/content/9/1/19
Heyndrickx L, Heath A, Sheik-Khalil E, Alcami J, Bongertz V, Jansson M, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Ramaswamy M, Sattentau Q, Tolazzi M, Schuitemaker H, Willems B, Wrin T, Fenyö EM, Scarlatti G, International network for comparison of HIV neutralization assays: the NeutNet report II, 2012, PLoS One, 7(5):e36438. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036438
Kreitchmann R, Harris DR, Kakehasi F, Haberer JE, Cahn P, Losso M, Teles E, Pilotto JH, Hofer CB, Read JS; NISDI LILAC Study Team. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS. 2012 Aug;26(8):486-95. http://online.liebertpub.com/doi/pdf/10.1089/apc.2012.0013
Martel N, Cotte L, Trabaud MA, Trepo C, Zoulim F, Gomes SA, Kay A, Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape, 2012, The Journal of Infectious Diseases; 205(11):1757-61. http://jid.oxfordjournals.org/content/early/2012/04/19/infdis.jis268
Mello FC, Lago BV, Lewis-Ximenez LL, Fernandes CA, Gomes SA., Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients, 2012, BMC Microbiology, 12: 96. http://www.biomedcentral.com/1471-2180/12/96
Monteiro S, Villela WV, Knauth D, Discrimination, stigma, and AIDS: a review of academic literature produced in Brazil (2005-2010), 2012, Cadernos de Saúde Pública 28(1):170-6. http://www.scielo.br/pdf/csp/v28n1/18.pdf
Monteiro S, Villela WV, Forum on stigma, discrimination, and health: policies and research challenges. Introduction, 2012, Cadernos de Saúde Pública; 28(1):161-3. http://www.scielosp.org/pdf/csp/v28n1/16.pdf
Mudd PA, Martins MA, Ericsen AJ, Tully DC, Power KA, Bean AT, Piaskowski SM, Duan L, Seese A, Gladden AD, Weisgrau KL, Furlott JR, Kim YI, Veloso de Santana MG, Rakasz E, Capuano S 3rd, Wilson NA, Bonaldo MC, Galler R, Allison DB, Piatak M Jr, Haase AT, Lifson JD, Allen TM, Watkins DI. Vaccine-induced CD8+ T cells control AIDS virus replication. Nature. 2012 Nov 1;491(7422):129-33. http://www.nature.com/nature/journal/v491/n7422/full/nature11443.html
Nabuco LC, Mello FC, Gomes Sde A, Perez RM, Soares JA, Coelho HS, Nogueira CA. Hepatitis B virus genotypes in Southeast Brazil and its relationship with histological features. Memórias do Instituto Oswaldo Cruz. 2012 Sep;107(6):785-9. http://www.scielo.br/pdf/mioc/v107n6/13.pdf
Nicol AF, Golub JE, e Silva JR, Cunha CB, Amaro-Filho SM, Oliveira NS, Menezes W, Andrade CV, Russomano F, Tristão A,Grinsztejn B, Friedman RK, Oliveira MP, Pires A, Nuovo GJ. An evaluation of p16INK4a expression in cervical intraepithelial neoplasia specimens, including women with HIV-1. Memórias do Instituto Oswaldo Cruz. 2012 Aug;107(5):571-7. http://www.scielo.br/pdf/mioc/v107n5/01.pdf
Nicol A, Monsonego J, Human papillomavirus, cervical cancer and other human diseases: translating research into practice, Future Virology, 2012, Vol. 7, No. 12, Pages 1153-1157. http://www.futuremedicine.com/doi/pdf/10.2217/fvl.12.106
Nicol AF, Lapa e Silva JR, Cunha CB, Amaro-Filho SM, Oliveira N, Grinsztejn B, Friedman RK, Russomano F, Pires A, Golub JE, Nuovo GJ. Evaluation of MCM-2 expression in TMA cervical specimens. PLoS One. 2012;7(4):e32936. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0032936
Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado D, Bethel J, Morgado MG, Dickover R, Camarca M, Mirochnick M, Siberry G, Grinsztejn B, Moreira RI, Bastos FI, Xu J, Moye J, Mofenson LM; NICHD HPTN 040/PACTG 1043 Protocol Team. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. The New England Journal of Medicine. 2012 Jun 21;366(25):2368-79. http://www.nejm.org/doi/full/10.1056/NEJMoa1108275
Passaes CP, Guimarães ML, Cardoso SW, Pilotto JH, Veloso V, Grinsztejn B, Morgado MG, Monitoring the emergence of resistance mutations in patients infected with HIV-1 under salvage therapy with raltegravir in Rio de Janeiro, Brazil: A follow-up study, Journal of Medical Virology,2012 Dec;84(12):1869-75. http://onlinelibrary.wiley.com/doi/10.1002/jmv.23409/abstract;jsessionid=6BC8407BCAFD3D2D91BEC966570FCE20.d01t01
Peres-da-Silva A, Almeida AJ, Lampe E, Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs, 2012, Memórias do Instituto Oswaldo Cruz, 107(2):254-61. http://memorias.ioc.fiocruz.br/issues/past-issues/item/1250-genetic-diversity-of-ns3-protease-from-brazilian-hcv-isolates-and-possible-implications-for-therapy-with-direct-acting-antiviral-drugs
Rangel HR, Maes M, Villalba J, Sulbarán Y, de Waard JH, Bello G, Pujol FH, Evidence of at Least Two Introductions of HIV-1 in the Amerindian Warao Population from Venezuela, 2012, PLoS One, 7(7):e40626. http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040626
Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H, Aneja J, Reyor LL, Allen TM, Lohse AW, McGovern B, Chung RT, Kwok WW, Kim AY, Lauer GM, Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence, 2012, Journal of Experimental Medicine, Jan 16;209(1):61-75. http://jem.rupress.org/content/209/1/61.long
Tourinho RS, de Almeida AJ, Amado LA, Villar LM, Castro AR, de Paula VS.Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas? Vaccine. 2012 Oct 5;30(45):6421-6. http://www.sciencedirect.com/science/article/pii/S0264410X12011942
Instituto Oswaldo Cruz /IOC /FIOCRUZ - Av. Brasil, 4365 - Tel: (21) 2598-4220
| INTRANET IOC| EXPEDIENTE
Manguinhos - Rio de Janeiro - RJ - Brasil CEP: 21040-360
